TXNRD2 and neoplasm: For example, MitoCur-1 selectively increases ROS generation in HCC cells by inhibiting thioredoxin reductase 2 (TrxR2), which simultaneously suppresses mitochondrial respiration and glycolytic metabolism, disrupting tumor metabolic plasticity [200].